Payments for Assay Development Sample Clauses

Payments for Assay Development. CFF will pay assay development milestones to Aurora upon ***. The characteristics of the assays and associated data required for evaluation as a CF Assay or CF-Related Assay will be made available to CFF and the Chemistry Advisory Group. Such assay(s) will *** validation and payment of such milestone. The milestone amount for the *** is *** dollars ($***) to be paid by CFF within *** days of notice by Aurora that such assay ***. The parties anticipate, subject to a greater understanding of the biology and chemistry of CF Targets by the parties, that during the Collaborative Period *** CF Assays or CF-Related Assays ***. New CF Targets under consideration, and a schedule for CF Target development and implementation in screening, are and will be described in the Work Plan. Validation of CF Assays and CF-Related Assays is subject to the approval of the Steering Committee after recommendation of the Collaboration Committee using guidelines described in the Agreement and such approval will take no longer than *** days. The first such assay is likely to be *** September 9, 1999 between the parties.
Sample 1
AutoNDA by SimpleDocs

Related to Payments for Assay Development

  • Joint Development All inventions, know-how, trade secrets, data or information which result from joint development by the Parties hereto shall be jointly owned by the Parties. The Parties hereby agree to cooperate in good faith in the filing of any and all patent applications in all jurisdictions.

  • Condominiums/Planned Unit Developments If the Mortgaged Property is a condominium unit or a planned unit development (other than a de minimis planned unit development) such condominium or planned unit development project such Mortgage Loan was originated in accordance with, and the Mortgaged Property meets the guidelines set forth in the Originator's Underwriting Guidelines;

  • Development Funding (a) Viewray will pay 3D Line the then U.S. Dollar equivalent of €[***] within three (3) days of the Effective Date for the engineering services required to develop/ deliver the Deliverable described in Section 2.1(a)(i).

  • Development 3.1.1 Licensee agrees to and warrants that:

  • Information Systems Acquisition Development and Maintenance a. Client Data – Client Data will only be used by State Street for the purposes specified in this Agreement.

  • Clinical Development (a) Stellartech shall design, develop and construct a Clinical Unit for each of the Thermage Disposable Device and the Thermage Generator, and any required component or subassembly thereof and shall deliver such Clinical Units to Thermage in accordance with the Development Program; (b) Stellartech shall deliver to Thermage such other Deliverables as are contemplated by the Development Program in accordance with the Development Program; and (c) as requested by Thermage and automatically at the conclusion of the Development Program, Stellartech, so long as Thermage is not in breach of its material obligation hereunder, shall deliver in writing to Thermage any and all data and information held by or in the control of Stellartech which is necessary or useful to obtain regulatory approval of the Products in the United States or any foreign country.

  • Initial Development Plan Not later than the Effective Date, Licensee shall have provided Merck with an initial Development plan for the Licensed Product in the Field in the Territory, which shall be incorporated as part of this Agreement as Attachment 3.02(a) (as may be amended in accordance with this Agreement, the “Development Plan”). **CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.

  • Subsequent Developments After the date of this Contract and until the Closing Date, Seller shall use best efforts to keep Buyer fully informed of all subsequent developments of which Seller has knowledge (“Subsequent Developments”) which would cause any of Seller’s representations or warranties contained in this Contract to be no longer accurate in any material respect.

  • Research and Development (i) Advice and assistance in relation to research and development of Party B;

  • Research Neither the Investor nor any Affiliate of the Investor shall have, in the prior thirty (30) days, published or distributed any research report (as such term is defined in Rule 500 of Regulation AC) concerning the Company.

Time is Money Join Law Insider Premium to draft better contracts faster.